Endocannabinoid System (ECS)
In brief: The endocannabinoid system (ECS) is a regulatory system found throughout the human body. It controls sleep, appetite, pain perception, and immune functions. THC and CBD from the cannabis plant bind to the same receptors as the body’s own endocannabinoids.
What is the Endocannabinoid System?
The endocannabinoid system was discovered in the early 1990s — through cannabis research, of all things. Scientists wanted to understand why the plant affects the human body at all. The answer: the body produces its own substances that resemble plant cannabinoids. Together with their receptors and enzymes, they form a distinct regulatory system.
The ECS consists of three components. First, endocannabinoids — the body’s own signaling molecules, mainly anandamide and 2-AG. Second, cannabinoid receptors CB1 and CB2, which are distributed throughout the body. Third, enzymes such as FAAH and MAGL that break down endocannabinoids after they have done their job.
The system regulates sleep, appetite, mood, pain perception, and immune responses, among other things. It works like a thermostat: when a process gets out of balance, the ECS sends signals to restore equilibrium.
CB1 Receptors: The Brain and the Senses
CB1 receptors are primarily located on nerve cells in the brain. They are especially abundant in the cerebellum, hippocampus, and cerebral cortex. They make up the largest portion of all G-protein-coupled receptors (GPCRs) in the brain.
When THC binds to CB1 receptors, sensory perception is intensified — sight, hearing, taste, and touch all become more vivid. Pain signaling is dampened and appetite is stimulated. At the same time, short-term memory can be impaired.
CB1 receptors have a neuroprotective function: they prevent excessively strong signals between nerve cells by regulating the release of neurotransmitters such as glutamate, serotonin, and dopamine.
Why a Cannabis Overdose Is Not Fatal
The brain stem, which controls vital functions like breathing and heartbeat, has virtually no CB1 receptors. That is why these basic functions remain unaffected even at high THC doses. Unlike opioids, which occupy receptors in the respiratory center, cannabis cannot stop breathing.
CB2 Receptors: The Immune System
CB2 receptors are found mainly on immune system cells — white blood cells, in the spleen, and in peripheral tissue. They contribute to anti-inflammatory action by dampening inflammatory responses, play a role in immune modulation by regulating the immune response, and can attenuate excessive allergic reactions.
THC also activates CB2 receptors. This explains part of the anti-inflammatory effect of cannabis in conditions like arthritis, Crohn’s disease, or multiple sclerosis.
Endocannabinoids: The Body’s Own Cannabinoids
The body produces two important endocannabinoids:
| Endocannabinoid | Discovery | Function |
|---|---|---|
| Anandamide (AEA) | 1992, named after Sanskrit “ananda” = bliss | Binds to CB1, influences mood, pain, appetite |
| 2-AG (2-Arachidonoylglycerol) | 1995 | Binds to CB1 and CB2, more abundant than anandamide |
Unlike neurotransmitters such as serotonin or dopamine, endocannabinoids are not stored in advance. They are synthesized on demand from fatty acids in cell membranes and immediately broken down by enzymes (FAAH and MAGL) after exerting their effect.
THC and CBD: Plant Cannabinoids at the ECS
The cannabis plant produces over 80 different cannabinoids. Two of them are the most studied for medical use:
| Cannabinoid | Receptor Action | Effect |
|---|---|---|
| THC (Tetrahydrocannabinol) | Partial agonist at CB1 receptor | Psychoactive, pain-relieving, appetite-stimulating, anti-inflammatory |
| CBD (Cannabidiol) | Weak antagonist, modulates CB1 indirectly | Non-psychoactive, antispasmodic, muscle-relaxing, anxiolytic |
An important finding: pure THC can cause anxiety, stress, or depressive moods in some patients. Only the combination of THC with CBD is perceived as pleasant by many users. The ratio of THC to CBD in the cannabis flower therefore influences the overall effect.
In the plant, THC and CBD are present as acids (THCA and CBDA) — without psychoactive effects. Only heat converts them into their active form. This process is called decarboxylation.
The ECS and Medical Research
Research on the endocannabinoid system is still in its early stages despite rapid progress. The system was only identified in the 1990s. Since then, it has become clear that it is involved in numerous processes — from bone formation and cancer development to neuroprotection.
Current research areas include ECS changes in chronic diseases and the targeted modulation of the ECS without psychoactive effects. Scientists are also investigating the interaction of endocannabinoids with other neurotransmitter systems and the role of the ECS in autoimmune diseases.
For the medical use of cannabis via vaporizer, understanding the ECS is fundamental: knowing how THC and CBD act at the receptors helps users choose temperature and strain more deliberately.
Sources
- Devane, W. A. et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258(5090), 1946–1949. PubMed 1470919
- Mechoulam, R. et al. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology, 50(1), 83–90. PubMed 7605349
- Pertwee, R. G. (2006). Cannabinoid pharmacology: the first 66 years. British Journal of Pharmacology, 147(S1), S163–S171. PubMed 16402100
- Lu, H. C. & Mackie, K. (2016). An Introduction to the Endogenous Cannabinoid System. Biological Psychiatry, 79(7), 516–525. PubMed 26698193
- Storz & Bickel / Vapormed (2023). Medical Cannabis: Introduction and Administration Methods. Vapormed GmbH, Tuttlingen.
Related Articles: Boiling Points · Cannabis Botany · Terpenes · Microdosing
Frequently Asked Questions
What is the Endocannabinoid System?
The ECS is an endogenous signaling system with CB1 receptors (brain/CNS) and CB2 receptors (immune system). It regulates pain perception, mood, appetite, sleep, and immune function.
How does cannabis affect the ECS?
THC binds directly to CB1 receptors, producing psychoactive effects. CBD modulates the ECS indirectly without intoxication. Both substances influence endogenous cannabinoid production.
Why is the ECS relevant for vaporizer users?
Vaporization temperature determines which cannabinoids are released and how they interact with the ECS. Lower temperatures (160–180 °C) emphasize THC/CBD, higher ones (200–230 °C) also activate CBN and CBC.
{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”What is the Endocannabinoid System?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The ECS is an endogenous signaling system with CB1 receptors (brain/CNS) and CB2 receptors (immune system). It regulates pain perception, mood, appetite, sleep, and immune function.”}},{“@type”:”Question”,”name”:”How does cannabis affect the ECS?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”THC binds directly to CB1 receptors, producing psychoactive effects. CBD modulates the ECS indirectly without intoxication. Both substances influence endogenous cannabinoid production.”}},{“@type”:”Question”,”name”:”Why is the ECS relevant for vaporizer users?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Vaporization temperature determines which cannabinoids are released and how they interact with the ECS. Lower temperatures (160–180 °C) emphasize THC/CBD, higher ones (200–230 °C) also activate CBN and CBC.”}}]}